Clinical Trial Update: Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dual-target Nectin-4/HER2 CAR-NK cells for advanced urothelial carcinomas, including bladder cancer, is currently recruiting a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Upper Tract Urothelial Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Dual-Target Nectin-4/HER2 CAR-NK Cells

Snippet

Sponsor: Beijing Biotech | Conditions: Bladder Cancer, Urothelial Carcinoma | Phase 1 | Status: RECRUITING